Paper23375686
Spectrum of mutations and phenotypic expression in patients with autosomal dominant hypercholesterolemia identified in Italy.
Bertolini S and 9 others. Atherosclerosis, 2013. Cited by 129 papers, by iCite.
Cite this record
ConductScience Library. Spectrum of mutations and phenotypic expression in patients with autosomal dominant hypercholesterolemia identified in Italy. Papers, record 23375686. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23375686
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Spectrum of mutations and phenotypic expression in patients with autosomal dominant hypercholesterolemia identified in Italy.
- PubMed
Topics23
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hyperlipoproteinemia Type II | Major topic |
| Mutation | Major topic |
| Adult | |
| Aged | |
| Alcohol Dehydrogenase | |
| Alleles | |
| Cholesterol, HDL | |
| Cholesterol, LDL | |
| Coronary Disease | |
| Female | |
| Genetic Association Studies | |
| Heterozygote | |
| Humans | |
| Italy | |
| Middle Aged | |
| Phenotype | |
| Proprotein Convertase 9 | |
| Proprotein Convertases | |
| Reference Values | |
| Serine Endopeptidases | |
| Smoking | |
| Tendons | |
| Xanthomatosis |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT03984149 | Lipa Gene Mutation in PED-LIPIGEN (Pediatric FH Subjects) | Background |
Source ClinicalTrials.gov
Cited by49
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 129 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42909552 | Heterozygous familial hypercholesterolemia in Italian children: a road map through a single center's experience. | Eur J Pediatr | 2026 | https://conductscience.org/library/papers/42909552 | PubMed |
| 40969606 | Metabolic syndrome: epidemiology, mechanisms, and current therapeutic approaches. | Front Nutr | 2025 | https://conductscience.org/library/papers/40969606 | PubMed |
| 40853479 | uAUG-creating variant in the LDLR gene causes mild Familial hypercholesterolemia. | Hum Genet | 2025 | https://conductscience.org/library/papers/40853479 | PubMed |
| 40510188 | Genetic variants and carotid atherosclerosis progression in familial hypercholesterolemia: a comprehensive review. | Front Cardiovasc Med | 2025 | https://conductscience.org/library/papers/40510188 | PubMed |
| 40428205 | Role of Next-Generation Sequencing in Diagnosis of Familial Hypercholesterolemia in Serbia. | Diagnostics (Basel) | 2025 | https://conductscience.org/library/papers/40428205 | PubMed |
| 40004776 | Coronary Artery Calcium Is Independently Associated with Arterial Stiffness and LDL Cholesterol Burden in Patients with Familial Hypercholesterolemia. | J Clin Med | 2025 | https://conductscience.org/library/papers/40004776 | PubMed |
| 39114568 | Cellular and functional evaluation of LDLR missense variants reported in hypercholesterolemic patients demonstrates their hypomorphic impacts on trafficking and LDL internalization. | Front Cell Dev Biol | 2024 | https://conductscience.org/library/papers/39114568 | PubMed |
| 38976372 | Sex differences in treatment of familial hypercholesterolaemia: a meta-analysis. | Eur Heart J | 2024 | https://conductscience.org/library/papers/38976372 | PubMed |
| 38308247 | LDLR gene rearrangements in Czech FH patients likely arise from one mutational event. | Lipids Health Dis | 2024 | https://conductscience.org/library/papers/38308247 | PubMed |
| 38236436 | Novel LDLR variants affecting low density lipoprotein metabolism identified in familial hypercholesterolemia. | Mol Biol Rep | 2024 | https://conductscience.org/library/papers/38236436 | PubMed |
| 38155796 | Clinical Characteristics of Homozygous Familial Hypercholesterolemia in Japan: A Survey Using a National Database. | JACC Asia | 2023 | https://conductscience.org/library/papers/38155796 | PubMed |
| 37887310 | Development of New Genome Editing Tools for the Treatment of Hyperlipidemia. | Cells | 2023 | https://conductscience.org/library/papers/37887310 | PubMed |
| 37108800 | Identification and Functional Analysis of APOB Variants in a Cohort of Hypercholesterolemic Patients. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37108800 | PubMed |
| 36769882 | Opportunistic Genetic Screening for Familial Hypercholesterolemia in Heart Transplant Patients. | J Clin Med | 2023 | https://conductscience.org/library/papers/36769882 | PubMed |
| 36499307 | Genetic Spectrum of Familial Hypercholesterolaemia in the Malaysian Community: Identification of Pathogenic Gene Variants Using Targeted Next-Generation Sequencing. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36499307 | PubMed |
| 36226792 | Expanding the genetic spectrum for Chinese familial hypercholesterolemia population with six genetic mutations identified using a next-generation sequencing-based laboratory-developed screening test. | Mol Genet Genomic Med | 2022 | https://conductscience.org/library/papers/36226792 | PubMed |
| 36196022 | Genetic and molecular architecture of familial hypercholesterolemia. | J Intern Med | 2023 | https://conductscience.org/library/papers/36196022 | PubMed |
| 35885941 | Clinical Aspects of Genetic and Non-Genetic Cardiovascular Risk Factors in Familial Hypercholesterolemia. | Genes (Basel) | 2022 | https://conductscience.org/library/papers/35885941 | PubMed |
| 35322671 | Twelve Variants Polygenic Score for Low-Density Lipoprotein Cholesterol Distribution in a Large Cohort of Patients With Clinically Diagnosed Familial Hypercholesterolemia With or Without Causative Mutations. | J Am Heart Assoc | 2022 | https://conductscience.org/library/papers/35322671 | PubMed |
| 35222552 | Assessment of Associations Between Serum Lipoprotein (a) Levels and Atherosclerotic Vascular Diseases in Hungarian Patients With Familial Hypercholesterolemia Using Data Mining and Machine Learning. | Front Genet | 2022 | https://conductscience.org/library/papers/35222552 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ADH1A | 124 | PubTator's text mining | https://conductscience.org/library/genes/124 | NCBI Gene |
| ADH1C | 126 | PubTator's text mining | https://conductscience.org/library/genes/126 | NCBI Gene |
| AKR1A1 | 10327 | PubTator's text mining | https://conductscience.org/library/genes/10327 | NCBI Gene |
| APOB | 338 | PubTator's text mining | https://conductscience.org/library/genes/338 | NCBI Gene |
| LDLR | 3949 | PubTator's text mining | https://conductscience.org/library/genes/3949 | NCBI Gene |
| PCSK9 | 255738 | PubTator's text mining | https://conductscience.org/library/genes/255738 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23375686
GET https://conductscience.org/api/papers/v1/23375686/cited_by?page=2